This summer, the Grammy Award-winning hip-hop icon Nas will become the first nationally renowned rap artist to perform with the Baltimore Symphony Orchestra in the organization’s 109-year history.

TRE-515, a small molecule inhibitor of deoxycytidine kinase, is being developed for autoimmune diseases and in clinical trials for tumors.

Proprio’s Paradigm AI guidance platform displays real-time progress during surgery, replacing X-ray and CT scans.

Proprio announced today that it received its second FDA 510(k) clearance for its Paradigm AI guidance platform for surgery.

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

Using approved MS drug Copaxone during pregnancy or breastfeeding does not appear to raise the risk of problems for the child ...

Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...

Pixel Watches have reportedly gained a small, QoL update for tiles alongside the recent Wear OS 5.1 update. Tiles now display ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

Merck last year signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat obesity. It also bought the rights to an early-stage cancer drug from ...

It covers Ozempic under Medicare Part D. Other insurance providers may also cover the cost of Ozempic when it’s used for its FDA-approved indications. This article discusses whether Medicare ...